Please use this identifier to cite or link to this item:
https://repository.unad.edu.co/handle/10596/33252
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Mendieta Zerón, Hugo | - |
dc.creator | Montenegro Cárdenas, Angela | - |
dc.creator | Vargas Hernández, Joel Alberto | - |
dc.creator | Hinojosa Juárez, Araceli Consuelo | - |
dc.date | 2019-11-15 | - |
dc.identifier | https://hemeroteca.unad.edu.co/index.php/nova/article/view/3637 | - |
dc.identifier | 10.22490/24629448.3637 | - |
dc.description | With the advent of antiretroviral therapy (ART), infection with the human immunodeficiency virus (HIV) has become a chronic disease with major metabolic complications more pronounced than in the general population. While there is no vaccineto eradicate infection rates and there is no cure for this pandemic, it should be more incisive in controlling comorbidities, among which alterations in the lipid profile stand out as they increase cardiovascular risk. | en-US |
dc.description | Con el advenimiento de la terapia antirretroviral (ART), la infección por el virus de inmunodeficiencia humana (VIH) se ha convertido en una enfermedad crónica con complicaciones metabólicas importantes más acentuadas que en la población general. Mientras no se tenga una vacuna que erradique las tasas de infección y no exista una cura para esta pandemia, se debe ser más incisivo en el controlar las comorbilidades, entre las que destacan las alteraciones en el perfil de lípidos pues aumentan el riesgo cardiovascular. | es-ES |
dc.format | application/pdf | - |
dc.language | spa | - |
dc.publisher | Universidad Colegio Mayor de Cundinamarca | es-ES |
dc.relation | https://hemeroteca.unad.edu.co/index.php/nova/article/view/3637/3679 | - |
dc.rights | Derechos de autor 2029 Nova | es-ES |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0 | es-ES |
dc.source | NOVA Biomedical Sciences Journal; Vol. 17 No. 32 (2019); 83 - 93 | en-US |
dc.source | Nova; Vol. 17 Núm. 32 (2019); 83 - 93 | es-ES |
dc.source | NOVA Ciências Biomédicas Publicação; v. 17 n. 32 (2019); 83 - 93 | pt-BR |
dc.source | 2462-9448 | - |
dc.source | 1794-2470 | - |
dc.subject | human immunodeficiency virus infection | en-US |
dc.subject | antiretroviral therapy | en-US |
dc.subject | lipid profile | en-US |
dc.subject | cardiovascular risk | en-US |
dc.subject | infección por el virus de inmunodeficiencia humana | es-ES |
dc.subject | terapia antirretroviral | es-ES |
dc.subject | perfil de lípidos | es-ES |
dc.subject | riesgo cardiovascular | es-ES |
dc.title | HIV, dyslipidemias and perspectives of its evolution | en-US |
dc.title | VIH, dislipidemias y perspectivas de su evolución | es-ES |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.type | reviewArticle | en-US |
dc.type | reviewArticle | es-ES |
dc.type | reviewArticle | pt-BR |
Appears in Collections: | Revista Nova |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.